Incidence of malformations since the introduction of thalidomide.
作者信息
LECK I M, MILLAR E L
出版信息
Br Med J. 1962 Jul 7;2(5296):16-20. doi: 10.1136/bmj.2.5296.16.
Abstract
摘要
相似文献
1
Incidence of malformations since the introduction of thalidomide.
Br Med J. 1962 Jul 7;2(5296):16-20. doi: 10.1136/bmj.2.5296.16.
2
Thalidomide and malformations in Liverpool.
Lancet. 1962 Jun 16;1(7242):1270-3. doi: 10.1016/s0140-6736(62)92367-x.
3
Congenital malformations attributed to sleeping pill (Thalidomide).
Eugen Q. 1962 Jun;9:95-7. doi: 10.1080/19485565.1962.9987510.
4
5
[Congenital abnormalities and thalidomide].
Ugeskr Laeger. 1962 Aug 24;124:1227-31.
6
Thalidomide and congenital abnormalities.
Lancet. 1962 Feb 10;1(7224):303-5. doi: 10.1016/s0140-6736(62)91248-5.
7
Thalidomide abnormalities.
Ugeskr Laeger. 1962 Aug 24;124:1250-1.
8
Thalidomide and congenital abnormalities.
Dev Med Child Neurol. 1962 Jun;4:338-9. doi: 10.1111/j.1469-8749.1962.tb03179.x.
9
Association of thalidomide (Kevadon) with congenital anomalies.
Can Med Assoc J. 1962 Apr 21;86(16):744-6.
10
Phocomelia and thalidomide.
Am J Obstet Gynecol. 1962 Oct 1;84:979. doi: 10.1016/0002-9378(62)90079-0.
引用本文的文献
1
Thalidomide-induced limb malformations: an update and reevaluation.
Arch Toxicol. 2025 May;99(5):1643-1747. doi: 10.1007/s00204-024-03930-z. Epub 2025 Apr 8.
2
Protocol of a prospective and multicentre China Teratology Birth Cohort (CTBC): association of maternal drug exposure during pregnancy with adverse pregnancy outcomes.
BMC Pregnancy Childbirth. 2021 Sep 1;21(1):593. doi: 10.1186/s12884-021-04073-0.
3
Hypnotic effect of thalidomide is independent of teratogenic ubiquitin/proteasome pathway.
Proc Natl Acad Sci U S A. 2020 Sep 15;117(37):23106-23112. doi: 10.1073/pnas.1917701117. Epub 2020 Aug 26.
4
Pathophysiology of Meningioma Growth in Pregnancy.
Open Med (Wars). 2017 Jul 13;12:195-200. doi: 10.1515/med-2017-0029. eCollection 2017.
5
Obesogens: an emerging threat to public health.
Am J Obstet Gynecol. 2016 May;214(5):559-65. doi: 10.1016/j.ajog.2016.01.182. Epub 2016 Jan 29.
6
Drug use before and during pregnancy in Serbia.
Int J Clin Pharm. 2012 Oct;34(5):719-27. doi: 10.1007/s11096-012-9665-8. Epub 2012 Jun 29.
7
Safety of Drugs.
Br Med J. 1962 Jul 28;2(5299):246-7.
8
The Thalidomide Legacy.
Proc R Soc Med. 1965 Jul;58(7):491-2. doi: 10.1177/003591576505800708.
9
Perspectives of primary care clinicians on teratogenic risk counseling.
Birth Defects Res A Clin Mol Teratol. 2009 Oct;85(10):858-63. doi: 10.1002/bdra.20599.
10
Can we ensure the safe use of known human teratogens? Introduction of generic isotretinoin in the US as an example.
Drug Saf. 2004;27(14):1069-80. doi: 10.2165/00002018-200427140-00001.
本文引用的文献
1
[On the problem of exogenous causes of severe malformations of the extremities].
Munch Med Wochenschr. 1962 Jan 12;104:68-74.
2
Congenital malformations after a two-hour inactivation of nicotinamide in pregnant mice.
Br Med J. 1960 Jul 16;2(5193):195-7. doi: 10.1136/bmj.2.5193.195.
3
Congenital thrombocytopenia associated with aplasia of the radius.
Acta Paediatr (Stockh). 1960 May;49:291-6. doi: 10.1111/j.1651-2227.1960.tb07736.x.
4
[Indications of a current increase of hypoplastic and aplastic deformities of the extremities].
Med Welt. 1961 Sep 16;37:1863-6.
5
[Thalidomide embryopathy. I. Incidence inside and outside Germany].
Dtsch Med Wochenschr. 1962 May 11;87:992-8 passim. doi: 10.1055/s-0028-1111856.
6
Thalidomide and congenital abnormalities.
Lancet. 1962 Feb 10;1(7224):303-5. doi: 10.1016/s0140-6736(62)91248-5.
7
Congenital malformations in inbred strains of mice induced by riboflavin-deficient, galactoflavin-containing diets.
J Exp Zool. 1957 Dec;136(3):531-65. doi: 10.1002/jez.1401360308.
8
Comparison of teratogenic chemicals in the rat and chick embryos; an exhibit with additions for publication.
Pediatrics. 1957 Apr;19(4 Pt 1):701-14.
9
Multiple congenital abnormalities in the rat resulting from riboflavin deficiency induced by the antimetabolite galactoflavin.
J Nutr. 1956 Jan 10;58(1):125-34. doi: 10.1093/jn/58.1.125.
Zotero 插件